User login
NATIONAL HARBOR, MD. – Treating menopause symptoms in women who still have a uterus can be difficult, but alternatives to estrogen are available.
For many women, the use of estrogen therapies is contraindicated – and even if it is prescribed, many women are noncompliant because of fears of increased risk of breast or uterine cancer, explained Dr. JoAnn Pinkerton of the University of Virginia, Charlottesville.
However, with the U.S. Food and Drug Administration’s recent approval of Duavee, a combination of conjugated estrogen and bazedoxifene, Dr. Pinkerton noted, women who don’t want to take estrogen have another option for quelling their menopause symptoms.
In an interview at the annual meeting of the North American Menopause Society, Dr. Pinkerton analyzes the benefits of combination therapy.
On Twitter @whitneymcknight
NATIONAL HARBOR, MD. – Treating menopause symptoms in women who still have a uterus can be difficult, but alternatives to estrogen are available.
For many women, the use of estrogen therapies is contraindicated – and even if it is prescribed, many women are noncompliant because of fears of increased risk of breast or uterine cancer, explained Dr. JoAnn Pinkerton of the University of Virginia, Charlottesville.
However, with the U.S. Food and Drug Administration’s recent approval of Duavee, a combination of conjugated estrogen and bazedoxifene, Dr. Pinkerton noted, women who don’t want to take estrogen have another option for quelling their menopause symptoms.
In an interview at the annual meeting of the North American Menopause Society, Dr. Pinkerton analyzes the benefits of combination therapy.
On Twitter @whitneymcknight
NATIONAL HARBOR, MD. – Treating menopause symptoms in women who still have a uterus can be difficult, but alternatives to estrogen are available.
For many women, the use of estrogen therapies is contraindicated – and even if it is prescribed, many women are noncompliant because of fears of increased risk of breast or uterine cancer, explained Dr. JoAnn Pinkerton of the University of Virginia, Charlottesville.
However, with the U.S. Food and Drug Administration’s recent approval of Duavee, a combination of conjugated estrogen and bazedoxifene, Dr. Pinkerton noted, women who don’t want to take estrogen have another option for quelling their menopause symptoms.
In an interview at the annual meeting of the North American Menopause Society, Dr. Pinkerton analyzes the benefits of combination therapy.
On Twitter @whitneymcknight
EXPERT ANALYSIS FROM THE NAMS ANNUAL MEETING